M&A Deal Summary |
|
|---|---|
| Date | 2022-04-20 |
| Target | Carterra LSA Instrument |
| Sector | Life Science |
| Buyer(s) | Genovac |
| Sellers(s) | Carterra |
| Deal Type | Divestiture |
SEARCH BY
Genovac is a contract research and manufacturing organization offering advanced antibody discovery solutions. Its immunization technologies, combined with multiple single-cell screening technologies, including Berkeley Lights’ Beacon, enable success against the most challenging targets. Genovac was founded in 1999 and is based in Freiburg, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Utah M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
Carterra is a provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra was founded in 2005 and is based in Salt Lake City, Utah.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 2 |
| State: Utah M&A | 1 of 2 |
| Country: United States M&A | 1 of 2 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-20 |
Carterra s LSA Instrument
Salt Lake City, Utah, United States Carterra's LSA Instrument which allows for high throughput surface plasmon resonance-based antibody characterizations thereby significantly increasing the Company’s capacity in performing various label-free protein interaction analyses including best-in-class kinetics, epitope binning, quantitation, epitope mapping, and blocking/neutralization assays. |
Sell | - |
